Thomas A. Werner
Duesseldorf, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
BRAFV600E mutation: A promising target in colorectal neuroendocrine carcinoma.
Journal: International journal of cancer
Published: January 15, 2018
IAPs cause resistance to TRAIL-dependent apoptosis in follicular thyroid cancer.
Journal: Endocrine-related cancer
Published: December 22, 2017
Establishment and Characterization of a Novel Cell Line Derived from a Small Cell Neuroendocrine Carcinoma of the Anal Canal.
Journal: Neuroendocrinology
Published: December 20, 2017
CXCR4/CXCR7/CXCL12-Axis in Follicular Thyroid Carcinoma.
Journal: Journal of Cancer
Published: September 27, 2017
Clinicopathological and functional implications of the inhibitor of apoptosis proteins survivin and XIAP in esophageal cancer.
Journal: Oncology letters
Published: July 04, 2017
CXCR4/CXCR7/CXCL12 axis promotes an invasive phenotype in medullary thyroid carcinoma.
Journal: British journal of cancer
Published: April 24, 2017
Survivin and XIAP expression in distinct tumor compartments of surgically resected gastric cancer: XIAP as a prognostic marker in diffuse and mixed type adenocarcinomas.
Journal: Oncology letters
Published: March 01, 2017
Survivin and XIAP - two potential biological targets in follicular thyroid carcinoma.
Journal: Scientific reports
Published: February 20, 2017
Preclinical assesement of survivin and XIAP as prognostic biomarkers and therapeutic targets in gastroenteropancreatic neuroendocrine neoplasia.
Journal: Oncotarget
Published: September 18, 2016
Survivin and XIAP: two valuable biomarkers in medullary thyroid carcinoma.
Journal: British journal of cancer
Published: October 30, 2015
Small bowel volvulus as a complication of von Recklinghausen's disease: a case report.
Journal: World journal of gastroenterology
Published: December 17, 2013
Showing 1-12 of 12
Last Updated: 09/26/2026